Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Chagas disease
CH-FDJP-CHE110141200-15
EUR 16.16mdeclared budget
EUR 13.52mdisbursed and spent, 1,193 of 1,193 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2006 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 14.37m → EUR 16.16m (+12.5%)
- Transactions added: 125 transactions added, EUR 2.40m
Chagas disease · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 2.43m | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 1.33m | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 3.00m | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 1.39m | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 1.60m | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 2.12m | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 2.51m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 1.79m | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 2.43m | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 1.33m | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 3.00m | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 1.39m | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 1.60m | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 2.12m | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 2.51m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2023-10-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-BR | |
| 2021-01-31 | Expenditure | EUR 4,383 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-AR | |
| 2021-01-31 | Expenditure | EUR 7,112 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-2-AR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR -10k | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-BR | |
| 2021-01-31 | Expenditure | EUR 406 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-2-BR | |
| 2021-01-31 | Expenditure | EUR 4,054 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-3-BR | |
| 2021-01-31 | Expenditure | EUR -16k | Drugs for Neglected Diseases initiative | Expenses - 15-2101-4-BR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 123 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-5-BR | |
| 2021-01-31 | Expenditure | EUR 2,111 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 3,563 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-ES-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 85k | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-FR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 2,100 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-GB | |
| 2021-01-31 | Expenditure | EUR 45 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-2-US | |
| 2021-01-31 | Expenditure | EUR 1,517 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-3-US-XM-DAC-7 | |
| 2021-01-31 | Expenditure | EUR 6,407 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-4-US | |
| 2021-01-31 | Expenditure | EUR 993 | Drugs for Neglected Diseases initiative | Expenses - 15-2101-5-US-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,194 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-1-BR | |
| 2021-02-28 | Expenditure | EUR 6,784 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-2-BR | |
| 2021-02-28 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 15-2102-3-BR-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 4,334 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-1-CH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 124 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-1-ES-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 6,129 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-1-GT | |
| 2021-02-28 | Expenditure | EUR 11 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-1-US | |
| 2021-02-28 | Expenditure | EUR 1,740 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-2-US-XM-DAC-7 | |
| 2021-02-28 | Expenditure | EUR 2,302 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-3-US | |
| 2021-02-28 | Expenditure | EUR 4,049 | Drugs for Neglected Diseases initiative | Expenses - 15-2102-4-US-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 1,208 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-1-BR | |
| 2021-03-31 | Expenditure | EUR 5,179 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-2-BR | |
| 2021-03-31 | Expenditure | EUR 7,724 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-3-BR-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 1,084 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-4-BR | |
| 2021-03-31 | Expenditure | EUR 4,328 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-1-CH-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 11 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-1-US | |
| 2021-03-31 | Expenditure | EUR 1,479 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-2-US-XM-DAC-7 | |
| 2021-03-31 | Expenditure | EUR 2 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-3-US | |
| 2021-03-31 | Expenditure | EUR 3,456 | Drugs for Neglected Diseases initiative | Expenses - 15-2103-4-US-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 9,262 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-1-BR | |
| 2021-04-30 | Expenditure | EUR 4,736 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-2-BR | |
| 2021-04-30 | Expenditure | EUR 3,433 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-3-BR-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 6,116 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-1-CH | |
| 2021-04-30 | Expenditure | EUR 2,490 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-1-GB | |
| 2021-04-30 | Expenditure | EUR 3,000 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-1-US | |
| 2021-04-30 | Expenditure | EUR 1,506 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-2-US-XM-DAC-7 | |
| 2021-04-30 | Expenditure | EUR 11 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-3-US | |
| 2023-01-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-BO | |
| 2023-01-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-BO-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR -15k | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-BR | |
| 2023-01-31 | Expenditure | EUR 269 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-BR | |
| 2023-01-31 | Expenditure | EUR 8,880 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-3-BR | |
| 2023-01-31 | Expenditure | EUR 9,000 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-4-BR-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR 46k | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-CH | |
| 2023-01-31 | Expenditure | EUR 6,843 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-CH | |
| 2023-01-31 | Expenditure | EUR 1,485 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-3-CH-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 15-2301-4-CH | |
| 2023-01-31 | Expenditure | EUR 6,747 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-5-CH-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR 4,267 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-CO | |
| 2023-01-31 | Expenditure | EUR 88 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-JP-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR 666 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-JP | |
| 2023-01-31 | Expenditure | EUR -518 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-KE | |
| 2023-01-31 | Expenditure | EUR 2,071 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-KE | |
| 2023-01-31 | Expenditure | EUR 231 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-3-KE-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR 2,373 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-US | |
| 2023-01-31 | Expenditure | EUR 6,470 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-2-US | |
| 2023-01-31 | Expenditure | EUR 3,389 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-3-US-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR 5,996 | Drugs for Neglected Diseases initiative | Expenses - 15-2301-1-ZA-CH-4 | |
| 2023-02-28 | Expenditure | EUR 8,726 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-BO-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 544 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-BR | |
| 2023-02-28 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 15-2302-2-BR | |
| 2023-02-28 | Expenditure | EUR 9,375 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-3-BR-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 33 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-CH | |
| 2023-02-28 | Expenditure | EUR 1,170 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-2-CH-XM-DAC-7 | |
| 2023-02-28 | Expenditure | EUR 3,161 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-3-CH | |
| 2023-02-28 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 15-2302-4-CH-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 4,195 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-CO | |
| 2023-02-28 | Expenditure | EUR 86k | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-FR-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 89 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-JP-XM-DAC-7 | |
| 2023-02-28 | Expenditure | EUR 675 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-2-JP | |
| 2023-02-28 | Expenditure | EUR 1,684 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-KE | |
| 2023-02-28 | Expenditure | EUR 259 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-2-KE-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 2,278 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-1-US | |
| 2023-02-28 | Expenditure | EUR 6,322 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-2-US | |
| 2023-02-28 | Expenditure | EUR 3,150 | Drugs for Neglected Diseases initiative | Expenses - 15-2302-3-US-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-AR | |
| 2023-03-31 | Expenditure | EUR 311 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-BR | |
| 2023-03-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 15-2303-2-BR | |
| 2023-03-31 | Expenditure | EUR 7,023 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-3-BR-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 33 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-CH | |
| 2023-03-31 | Expenditure | EUR 6,875 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-2-CH-XM-DAC-7 | |
| 2023-03-31 | Expenditure | EUR 3,178 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-3-CH | |
| 2023-03-31 | Expenditure | EUR 9,290 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-4-CH-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 4,221 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-CO | |
| 2023-03-31 | Expenditure | EUR 689 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-FR-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 102 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-JP-XM-DAC-7 | |
| 2023-03-31 | Expenditure | EUR 688 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-2-JP | |
| 2023-03-31 | Expenditure | EUR 1,781 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-KE | |
| 2023-03-31 | Expenditure | EUR 924 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-2-KE-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 2,289 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-1-US | |
| 2023-03-31 | Expenditure | EUR 6,530 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-2-US | |
| 2023-03-31 | Expenditure | EUR 5,549 | Drugs for Neglected Diseases initiative | Expenses - 15-2303-3-US-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-BO | |
| 2023-04-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-BO | |
| 2023-04-30 | Expenditure | EUR 3,655 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-3-BO-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-BR | |
| 2023-04-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-BR | |
| 2023-04-30 | Expenditure | EUR 2,529 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-3-BR-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 1,330 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-CH | |
| 2023-04-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-CH-XM-DAC-7 | |
| 2023-04-30 | Expenditure | EUR 2,117 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-3-CH | |
| 2023-04-30 | Expenditure | EUR 7,824 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-4-CH-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 4,219 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-CO | |
| 2023-04-30 | Expenditure | EUR 101 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-JP-XM-DAC-7 | |
| 2023-04-30 | Expenditure | EUR 687 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-JP | |
| 2023-04-30 | Expenditure | EUR 1,720 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-KE | |
| 2023-04-30 | Expenditure | EUR 265 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-KE-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 7,574 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-1-US | |
| 2023-04-30 | Expenditure | EUR 6,550 | Drugs for Neglected Diseases initiative | Expenses - 15-2304-2-US | |
| 2023-05-31 | Expenditure | EUR 48k | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-BR | |
| 2023-05-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 15-2305-2-BR | |
| 2023-05-31 | Expenditure | EUR 2,472 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-CH | |
| 2023-05-31 | Expenditure | EUR 1,681 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-2-CH | |
| 2023-05-31 | Expenditure | EUR 4,483 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-3-CH-XM-DAC-7 | |
| 2023-05-31 | Expenditure | EUR 2,130 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-4-CH | |
| 2023-05-31 | Expenditure | EUR 8,655 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-5-CH-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 4,122 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-CO | |
| 2023-05-31 | Expenditure | EUR 99 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-JP-XM-DAC-7 | |
| 2023-05-31 | Expenditure | EUR 675 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-2-JP | |
| 2023-05-31 | Expenditure | EUR 1,624 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-KE | |
| 2023-05-31 | Expenditure | EUR 1,009 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-2-KE-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 6,260 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-1-US | |
| 2023-05-31 | Expenditure | EUR 8,761 | Drugs for Neglected Diseases initiative | Expenses - 15-2305-2-US | |
| 2023-06-30 | Expenditure | EUR 119k | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-AR | |
| 2023-06-30 | Expenditure | EUR 39k | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-BO | |
| 2023-06-30 | Expenditure | EUR 4,840 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-2-BO-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-BR | |
| 2023-06-30 | Expenditure | EUR 4,725 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-2-BR | |
| 2023-06-30 | Expenditure | EUR 17 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-3-BR-XM-DAC-7 | |
| 2023-06-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 15-2306-4-BR | |
| 2023-06-30 | Expenditure | EUR 6,167 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-CH | |
| 2023-06-30 | Expenditure | EUR 1,666 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-2-CH | |
| 2023-06-30 | Expenditure | EUR 2,315 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-3-CH-XM-DAC-7 | |
| 2023-06-30 | Expenditure | EUR 2,315 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-4-CH | |
| 2023-06-30 | Expenditure | EUR 8,387 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-5-CH-GB-GOV-1 | |
| 2023-10-31 | Expenditure | EUR 1,204 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-2-BR | |
| 2023-10-31 | Expenditure | EUR 3,356 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-3-BR | |
| 2023-10-31 | Expenditure | EUR 2,537 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-CH | |
| 2023-10-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 15-2310-2-CH | |
| 2023-10-31 | Expenditure | EUR 1,692 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-3-CH | |
| 2023-10-31 | Expenditure | EUR 963 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-4-CH | |
| 2023-10-31 | Expenditure | EUR 4,233 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-CO | |
| 2023-10-31 | Expenditure | EUR 4,152 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-2-CO | |
| 2023-10-31 | Expenditure | EUR 9,000 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-ES | |
| 2023-10-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-FR | |
| 2023-10-31 | Expenditure | EUR 98 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-JP | |
| 2023-10-31 | Expenditure | EUR 628 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-2-JP | |
| 2023-10-31 | Expenditure | EUR 774 | Drugs for Neglected Diseases initiative | Expenses - 15-2310-1-KE | |
| 2023-06-30 | Expenditure | EUR 8,927 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-CO | |
| 2023-06-30 | Expenditure | EUR 800 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-ES-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 2,010 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-FR-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 766 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-JP | |
| 2023-06-30 | Expenditure | EUR 2,410 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-KE | |
| 2023-06-30 | Expenditure | EUR 2,585 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-2-KE-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 9,601 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-1-US | |
| 2023-06-30 | Expenditure | EUR 2,751 | Drugs for Neglected Diseases initiative | Expenses - 15-2306-2-US | |
| 2023-07-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-BR | |
| 2023-07-31 | Expenditure | EUR 4,311 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-2-BR | |
| 2023-07-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 15-2307-3-BR | |
| 2023-07-31 | Expenditure | EUR 2,495 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-CH | |
| 2023-07-31 | Expenditure | EUR 2,600 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-2-CH | |
| 2023-07-31 | Expenditure | EUR 1,663 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-3-CH | |
| 2023-07-31 | Expenditure | EUR 175 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-4-CH-XM-DAC-7 | |
| 2023-07-31 | Expenditure | EUR 175 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-5-CH | |
| 2023-07-31 | Expenditure | EUR 8,375 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-6-CH-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 4,168 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-CO | |
| 2023-07-31 | Expenditure | EUR 85k | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-FR-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 6,136 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-GT | |
| 2023-07-31 | Expenditure | EUR 95 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-JP | |
| 2023-07-31 | Expenditure | EUR 647 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-2-JP | |
| 2023-07-31 | Expenditure | EUR 3,203 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-KE | |
| 2023-07-31 | Expenditure | EUR 7,759 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-2-KE-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 9,800 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-1-US | |
| 2023-07-31 | Expenditure | EUR 2,287 | Drugs for Neglected Diseases initiative | Expenses - 15-2307-2-US | |
| 2023-08-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-AR | |
| 2023-08-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-BR | |
| 2023-08-31 | Expenditure | EUR 1,191 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-2-BR | |
| 2023-08-31 | Expenditure | EUR 9,268 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-3-BR | |
| 2023-08-31 | Expenditure | EUR 2,522 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-CH | |
| 2023-08-31 | Expenditure | EUR 2,629 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-2-CH | |
| 2023-08-31 | Expenditure | EUR 1,682 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-3-CH | |
| 2023-08-31 | Expenditure | EUR 8,465 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-4-CH-GB-GOV-1 | |
| 2023-08-31 | Expenditure | EUR 4,101 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-CO | |
| 2023-08-31 | Expenditure | EUR 93 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-JP | |
| 2023-08-31 | Expenditure | EUR 632 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-2-JP | |
| 2023-08-31 | Expenditure | EUR 3,877 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-KE | |
| 2023-08-31 | Expenditure | EUR 4,076 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-2-KE-GB-GOV-1 | |
| 2023-08-31 | Expenditure | EUR 8,139 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-1-US | |
| 2023-08-31 | Expenditure | EUR 2,083 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-2-US | |
| 2023-08-31 | Expenditure | EUR 22 | Drugs for Neglected Diseases initiative | Expenses - 15-2308-3-US | |
| 2023-09-30 | Expenditure | EUR 8,358 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-AR | |
| 2023-09-30 | Expenditure | EUR 2,292 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-BO | |
| 2023-09-30 | Expenditure | EUR 244 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-BR | |
| 2023-09-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 15-2309-2-BR | |
| 2023-09-30 | Expenditure | EUR 1,364 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-3-BR | |
| 2023-09-30 | Expenditure | EUR 1,367 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-4-BR | |
| 2023-09-30 | Expenditure | EUR 2,541 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-CH | |
| 2023-09-30 | Expenditure | EUR 3,993 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-2-CH | |
| 2023-09-30 | Expenditure | EUR 1,694 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-3-CH | |
| 2023-09-30 | Expenditure | EUR 8,529 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-4-CH-GB-GOV-1 | |
| 2023-09-30 | Expenditure | EUR 4,143 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-CO | |
| 2023-09-30 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-FR | |
| 2023-09-30 | Expenditure | EUR 98 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-JP | |
| 2023-09-30 | Expenditure | EUR 629 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-2-JP | |
| 2023-09-30 | Expenditure | EUR 3,089 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-KE | |
| 2023-09-30 | Expenditure | EUR 3,991 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-2-KE-GB-GOV-1 | |
| 2023-09-30 | Expenditure | EUR 1,100 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-1-US | |
| 2023-09-30 | Expenditure | EUR 549 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-2-US | |
| 2023-09-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 15-2309-3-US | |
| 2023-09-30 | Expenditure | EUR 3,348 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-4-US | |
| 2023-09-30 | Expenditure | EUR 4,584 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-5-US | |
| 2023-09-30 | Expenditure | EUR 220 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-6-US-CH-4 | |
| 2023-09-30 | Expenditure | EUR 3,095 | Drugs for Neglected Diseases initiative | Expenses - 15-2309-7-US | |
| 2021-04-30 | Expenditure | EUR 502 | Drugs for Neglected Diseases initiative | Expenses - 15-2104-4-US-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR -535 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-BE-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 8,900 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-BR | |
| 2021-05-31 | Expenditure | EUR 3,853 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-2-BR | |
| 2021-05-31 | Expenditure | EUR 4,827 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-3-BR-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 1,875 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-4-BR | |
| 2021-05-31 | Expenditure | EUR 6,134 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-CH | |
| 2021-05-31 | Expenditure | EUR 1,172 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-CO | |
| 2021-05-31 | Expenditure | EUR 85k | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-FR | |
| 2021-05-31 | Expenditure | EUR 2,937 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-1-US | |
| 2021-05-31 | Expenditure | EUR 1,458 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-2-US-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR -16 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-3-US | |
| 2021-05-31 | Expenditure | EUR 489 | Drugs for Neglected Diseases initiative | Expenses - 15-2105-4-US-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 175k | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-AR | |
| 2021-06-30 | Expenditure | EUR 5,424 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-BO-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-BR | |
| 2021-06-30 | Expenditure | EUR 7,738 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-2-BR | |
| 2021-06-30 | Expenditure | EUR 6,068 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-3-BR-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 1,158 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-4-BR | |
| 2021-06-30 | Expenditure | EUR 6,828 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-CH | |
| 2021-06-30 | Expenditure | EUR 1,058 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-FR | |
| 2021-06-30 | Expenditure | EUR 574 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-2-FR | |
| 2021-06-30 | Expenditure | EUR 1,260 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-GB | |
| 2021-06-30 | Expenditure | EUR 4,397 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-1-US | |
| 2021-06-30 | Expenditure | EUR 2,212 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-2-US-XM-DAC-7 | |
| 2021-06-30 | Expenditure | EUR 20 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-3-US | |
| 2021-06-30 | Expenditure | EUR 733 | Drugs for Neglected Diseases initiative | Expenses - 15-2106-4-US-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 15-2107-1-BR | |
| 2021-07-31 | Expenditure | EUR 1,529 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-2-BR | |
| 2021-07-31 | Expenditure | EUR 7,689 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-3-BR | |
| 2021-07-31 | Expenditure | EUR 3,485 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-4-BR-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 765 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-5-BR | |
| 2021-07-31 | Expenditure | EUR -33k | Drugs for Neglected Diseases initiative | Expenses - 15-2107-1-CH | |
| 2021-07-31 | Expenditure | EUR 1,836 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-1-FR | |
| 2021-07-31 | Expenditure | EUR 1,080 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-2-FR | |
| 2021-07-31 | Expenditure | EUR 49k | Drugs for Neglected Diseases initiative | Expenses - 15-2107-1-GB-XM-DAC-7 | |
| 2021-07-31 | Expenditure | EUR 2,967 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-1-US | |
| 2021-07-31 | Expenditure | EUR 1,483 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-2-US-XM-DAC-7 | |
| 2021-07-31 | Expenditure | EUR 494 | Drugs for Neglected Diseases initiative | Expenses - 15-2107-3-US-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 15-2108-1-BR | |
| 2021-08-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 15-2108-2-BR | |
| 2021-08-31 | Expenditure | EUR 3,955 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-3-BR-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 2,158 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-4-BR | |
| 2021-08-31 | Expenditure | EUR 6,237 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-1-CH | |
| 2021-08-31 | Expenditure | EUR 3,715 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-1-CO | |
| 2021-08-31 | Expenditure | EUR 3,459 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-2-CO | |
| 2021-08-31 | Expenditure | EUR 2,500 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-1-GB | |
| 2021-08-31 | Expenditure | EUR 3,023 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-1-US | |
| 2021-08-31 | Expenditure | EUR 1,512 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-2-US-XM-DAC-7 | |
| 2021-08-31 | Expenditure | EUR 504 | Drugs for Neglected Diseases initiative | Expenses - 15-2108-3-US-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-BR | |
| 2021-09-30 | Expenditure | EUR 7,839 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-2-BR | |
| 2021-09-30 | Expenditure | EUR 4,993 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-3-BR-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 3,344 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-4-BR | |
| 2021-09-30 | Expenditure | EUR -1,023 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-CH | |
| 2021-09-30 | Expenditure | EUR 3,487 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-CO | |
| 2021-09-30 | Expenditure | EUR 7,872 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-2-CO | |
| 2021-09-30 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-FR-XM-DAC-7 | |
| 2021-09-30 | Expenditure | EUR 500 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-GB | |
| 2021-09-30 | Expenditure | EUR 3,038 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-1-US | |
| 2021-09-30 | Expenditure | EUR 1,517 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-2-US-XM-DAC-7 | |
| 2021-09-30 | Expenditure | EUR -3 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-3-US | |
| 2021-09-30 | Expenditure | EUR 506 | Drugs for Neglected Diseases initiative | Expenses - 15-2109-4-US-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 15-2110-1-BR | |
| 2021-10-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 15-2110-2-BR | |
| 2021-10-31 | Expenditure | EUR 1,784 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-3-BR-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 6,233 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-1-CH | |
| 2021-10-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 15-2110-1-CO | |
| 2021-10-31 | Expenditure | EUR 3,653 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-2-CO | |
| 2021-10-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 15-2110-3-CO | |
| 2021-10-31 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 15-2110-1-FR | |
| 2021-10-31 | Expenditure | EUR 1,519 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-1-US-XM-DAC-7 | |
| 2021-10-31 | Expenditure | EUR 3,037 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-2-US | |
| 2021-10-31 | Expenditure | EUR 506 | Drugs for Neglected Diseases initiative | Expenses - 15-2110-3-US-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 15-2111-1-BR | |
| 2021-11-30 | Expenditure | EUR 3,945 | Drugs for Neglected Diseases initiative | Expenses - 15-2111-2-BR | |
| 2021-11-30 | Expenditure | EUR 8,678 | Drugs for Neglected Diseases initiative | Expenses - 15-2111-3-BR | |
| 2021-11-30 | Expenditure | EUR 454 | Drugs for Neglected Diseases initiative | Expenses - 15-2111-4-BR-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 3,796 | Drugs for Neglected Diseases initiative | Expenses - 15-2111-5-BR | |
| 2021-11-30 | Expenditure | EUR 6,321 | Drugs for Neglected Diseases initiative | Expenses - 15-2111-1-CH |
Showing 300 of 1,193. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.